Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,084.27%
#4 Black Phoenix Black Phoenix +336.48%
#5 aPriori aPriori +113.53%
#6 Bedrock Bedrock +74.54%
#7 Cysic Cysic +46.36%
#8 Prom Prom +40.86%
#9 Playnance Playnance +34.97%
#10 COTI COTI +30.93%
Coin of the day
Wrapped One Wrapped One
設定
言語
日本
通貨
USD
テーマ
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
株式のランク #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
株価
$0.0009
最終同期: 2025-05-27
時価総額
$1.15K
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Arch Therapeutics, Inc. (ARTH)

カテゴリー

Healthcare
Arch Therapeutics, Inc.（ARTH）の株価履歴
終値の最高値: $0.00 （2025-05-01）

終値の最安値: $3.67K （2012-12-01）
Arch Therapeutics, Inc. の株価履歴（2012 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2025 -99.61%
2024 -97.03%
2023 -5.00%
2022 -64.68%
2021 -28.45%
2020 -99.69%
2019 -51.23%
2018 -17.82%
2017 1.40%
2016 175.64%
2015 5.30%
2014 -2.69%
2013 131.37%
2012 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR